HAX1 stabilization could enhance the binding between RAF1, MEK and ERK1/2, thereby potentiating phosphorylation of ERK1/2, which in turn promotes CRC tumorigenesis and metastasis. The gene discussed is HAX1; the disease is colorectal carcinoma.